CVS vs REGN · P/E 16, rev $402.07B vs P/E 14, rev $14.34B
CVS Health Corp (CVS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CVS and REGN stock pages for the full models.
Not investment advice.